Successful diagnosis and endoscopic submucosal dissection of a gastric gastrointestinal stromal tumor originating from the submucosal layer

por Shimura, Takaya, Sugimura, Naomi, Iwasaki, Hiroyasu, Katano, Takahito, Kataoka, Hiromi
Publicado 2022

The efficacy of maintenance therapy after remission induction with tacrolimus in ulcerative colitis with and without previous tumor necrosis factor‐α inhibitor

por Suzuki, Taketo, Mizoshita, Tsutomu, Tanida, Satoshi, Sugimura, Naomi, Katano, Takahito, Nishie, Hirotada, Kataoka, Hiromi
Publicado 2019

A case of asymptomatic gastric plexiform fibromyxoma followed up for 3 years

por Sugimura, Naomi, Kubota, Eiji, Sasaki, Makiko, Fukusada, Shigeki, Mizuno, Yusuke, Iwasaki, Hiroyasu, Tanaka, Mamoru, Ozeki, Keiji, Shimura, Takaya, Kataoka, Hiromi
Publicado 2023

Prospective comparison of preference and efficacy of adalimumab and infliximab for treating ulcerative colitis naive to antitumor necrosis factor therapy

por Mizoshita, Tsutomu, Katano, Takahito, Tanida, Satoshi, Hirano, Atsuyuki, Miyaki, Tomokatsu, Ozeki, Keiji, Suzuki, Yuka, Sugimura, Naomi, Kataoka, Hiromi, Joh, Takashi
Publicado 2017

Combination Therapy With Ustekinumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis

por Tanida, Satoshi, Ozeki, Keiji, Kanno, Takuya, Katano, Takahito, Sugimura, Naomi, Nishie, Hirotada, Iwasaki, Hiroyasu, Tanaka, Mamoru, Shimura, Takaya, Kubota, Eiji, Kataoka, Hiromi
Publicado 2021

Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn's Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatmen...

por Suzuki, Taketo, Mizoshita, Tsutomu, Sugiyama, Tomoya, Hirata, Yoshikazu, Kimura, Yoshihide, Suzuki, Yuka, Yamada, Tomonori, Tsukamoto, Hironobu, Mizushima, Takashi, Sugimura, Naomi, Katano, Takahito, Tanida, Satoshi, Kataoka, Hiromi, Sasaki, Makoto
Publicado 2019